SCIMITAR

Smoking is an important health issue, not just in the general public, but also among people with severe mental illness. A large proportion of people who have experienced severe mental illnesses, such as schizophrenia or bipolar disorder, smoke.

This study is looking to evaluate a ‘bespoke smoking cessation’ (BSC) service specifically tailored to individual patients with severe mental illness. Participants will either receive care as normal or the BSC. Participants recruited to the study will be followed up for 12 months. After 6 and 12 months they will be requested to complete questionnaires on their smoking status, general and mental health and their satisfaction with specified aspects of the BSC. They will also have their smoking status verified by measuring the amount of carbon monoxide in their breath.

This study has now closed to recruitment.

Findings so far:

The main findings of SCIMITAR are that smoking cessation can be achieved among people with severe mental ill health and that use of a bespoke smoking cessation intervention might increase engagement with services and boost the chances of sustained quitting.

Please click this link to go to the SCIMITAR website.

For more information please complete the following form:

First name * The 'First name' field is required

Last name * The 'Last name' field is required

Email address * Please enter a valid Email address

Telephone

Message